1Epstein MA, Achong BG, Ban" YM. Virus particles in cultured lymphoblasts from Burkitt' s lymphoma [ J]. Lancet 1964, 1 : 702- 703.
2Old L J, Boyse E A,Oettgen H F,et al. Precipitating Antibody in Human Serum to an Antigen Present in Cultured Burkitt's Lymphoma Cells[J]. Proc Natl Acad Sci U S A 1966, 56:1699- 1704.
4Zong YS, Sham JS, Ng MH, et al. Immunoglobulin Aagainst viral capsid antigen of Epstein-Barr virus and indirect examination of the nasapharynx in the detection of nasopharyngeal carcinoma [J]. Cancer 1992,69( 1 ) :3.
9Feng P, Ren EC, Liu D, et al. Expression of EBV lytic gene BRLF 1 in nasopharyngeal carcinoma: potential use in diagnosis [ J]. J Gen Virol, 2000, 81:2417- 2423.
7[2]Lo YM, Chan LY, Lo KW, et al. Quantitative analysis of cellfree Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma[J]. Cancer Res, 1999, 59(6):1188～1191
8[3]Anker P, Mulcahy H, Chen XQ, et al. Detection of circulating tumor DNA in blood (plasma/serum) of cancer patients[J]. Cancer Metastasis Rev, 1999, 18(1): 65～73
9[4]Mutirangura A, Pomthanakasem W, Theamboonlers A, et al.Epstein-Barr viral DNA in serum of patients in nasopharyngeal carcinoma[J]. Clin Cancer Res, 1998, 4(3): 665～669
10[5]Shotelesuk K, Khorprasert C, Sakdikul S, et al. Epstein-Bart viral DNA in serum/plasma as a tumor marker for nasopharyngeal carcinoma[J]. Clin Cancer Res, 2000, 6(3): 1046～1051
